Allergic Conjunctivitis (AC) Market Insights, Epidemiology & Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--()--The "Allergic Conjunctivitis (AC) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of AC in the United States, EU5, and Japan.

The Allergic Conjunctivitis (AC) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.

This segment of the Allergic Conjunctivitis report encloses the detailed analysis of marketed drugs and late stage pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

At present, there are mainly eight therapeutic classes of drugs contributing towards the market size of AC - Decongestants/Antihistamines, Corticosteroids, Topical Histamines, Systemic Histamines, Mast cell stabilizers (MCS), Immunomodulators, Nonsteroidal anti-inflammatory drugs (NSAIDs) and Dual acting Antihistamines/Mast cell stabilizers.

The Allergic Conjunctivitis market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

Companies Mentioned

  • Nicox Pharma - Allergan
  • Aldeyra Therapeutics - Valeant
  • ORA, Inc. - Novartis
  • Ocular Therapeutix, Inc. - Pfizer
  • Santen Pharma - Medpointe
  • Faes Pharma - Bausche & Lombe

Key Topics Covered:

1. Key Insights

2. Allergic Conjunctivitis Market Overview at a Glance

3. Disease Background and Overview: Allergic Conjunctivitis (AC)

4. Epidemiology and Patient Population

5. Key Findings

6. Country Wise-Epidemiology of Allergic Conjunctivitis

7. Treatment Agorithm

8. Unmet needs

9. Marketed Drugs

10. Emerging Drugs

11. Allergic Conjunctivitis: 7 Major Market Analysis

12. Market Outlook by Country

13. the United States: Market Outlook

14. EU-5 Countries: Market Outlook

15. Japan: Market Outlook

16. Market Drivers

17. Market Barriers

18. Appendix

19. Report Methodology

20. Capabilities

21. Disclaimer

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/q8vsr9/allergic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Allergy Drugs , Optical Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Allergy Drugs , Optical Disorders Drugs